These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2144431)

  • 121. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27.
    Thomsen BS; Jacobsen SE; Nielsen H; Jakobsen BK; Sørensen H
    Complement; 1986; 3(2):79-87. PubMed ID: 2945696
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Altered erythrocyte CR1 binding kinetics compensate for decreased binding capacity in rheumatoid arthritis.
    Hargrove JK; Meryhew NL; Runquist OA
    J Clin Chem Clin Biochem; 1990 Aug; 28(8):533-41. PubMed ID: 2147952
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.
    Cornillet P; Gredy P; Pennaforte JL; Meyer O; Kazatchkine MD; Cohen JH
    Clin Exp Immunol; 1992 Jul; 89(1):22-5. PubMed ID: 1352746
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry.
    Kisserli A; Audonnet S; Duret V; Tabary T; Cohen JHM; Mahmoudi R
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510517
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases.
    Yen JH; Liu HW; Lin SF; Chen TP
    Rheumatol Int; 1990; 10(2):71-3. PubMed ID: 2349436
    [TBL] [Abstract][Full Text] [Related]  

  • 126. The role of complement in the aetiopathogenesis of systemic lupus erythematosus.
    Gatenby PA
    Autoimmunity; 1991; 11(1):61-6. PubMed ID: 1839881
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Polymer microbeads bound to C3 fragments for detecting and labeling cells with C3 receptors.
    Uchida T; Hosaka S; Murao Y
    Immunol Commun; 1982; 11(6):467-76. PubMed ID: 6220961
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Quantification of IgG on erythrocytes of patients and normals by a radio-ligand-binding assay.
    Giles CM; Davies KA; Loizou S; Moulds JJ; Walport MJ
    Transfus Med; 1991 Dec; 1(4):223-8. PubMed ID: 9259853
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.
    Van Dyne S; Holers VM; Lublin DM; Atkinson JP
    Clin Exp Immunol; 1987 Jun; 68(3):570-9. PubMed ID: 2958190
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.
    Bengtsson AA; Tyden H; Lood C
    Arthritis Res Ther; 2020 May; 22(1):126. PubMed ID: 32471491
    [TBL] [Abstract][Full Text] [Related]  

  • 131. The biology and pathophysiology of complement receptors.
    Lambris JD; Tsokos GC
    Anticancer Res; 1986; 6(3 Pt B):515-23. PubMed ID: 2943215
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Immunohistochemical studies of complement receptor (CR1) in cases with normal sinus mucosa and chronic sinusitis.
    Miyaguchi M; Uda H; Sakai S; Kubo T; Matsunaga T
    Arch Otorhinolaryngol; 1988; 244(6):350-4. PubMed ID: 2964819
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Assays for membrane complement receptors.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.4.1-13.4.18. PubMed ID: 18432717
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.
    Brekke OL; Hellerud BC; Christiansen D; Fure H; Castellheim A; Nielsen EW; Pharo A; Lindstad JK; Bergseth G; Leslie G; Lambris JD; Brandtzaeg P; Mollnes TE
    Mol Immunol; 2011 Sep; 48(15-16):2159-69. PubMed ID: 21839519
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
    Fahnoe KC; Liu F; Morgan JG; Ryan ST; Storek M; Stark EG; Taylor FR; Holers VM; Thurman JM; Wawersik S; Kalled SL; Violette SM
    Front Immunol; 2022; 13():869725. PubMed ID: 35784298
    [TBL] [Abstract][Full Text] [Related]  

  • 136. The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors.
    Miot S; Marfurt J; Lach-Trifilieff E; González-Rubio C; López-Trascasa M; Sadallah S; Schifferli JA
    Blood Cells Mol Dis; 2002; 29(2):200-12. PubMed ID: 12490287
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Size polymorphism of the erythrocyte complement receptor type 1 (CR1) in systemic lupus erythematosus induced by hydralazine.
    Mitchell JA; Sim E
    Complement Inflamm; 1989; 6(2):88-93. PubMed ID: 2721176
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Neoepitopes expressed by immune complexes.
    Amlot PL
    Complement Inflamm; 1989; 6(3):236-48. PubMed ID: 2472925
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.
    Arakelyan A; Zakharyan R; Khoyetsyan A; Poghosyan D; Aroutiounian R; Mrazek F; Petrek M; Boyajyan A
    BMC Clin Pathol; 2011 Aug; 11():10. PubMed ID: 21867543
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Rate of antigen entry into the circulation in experimental versus naturally occurring immune complex glomerulonephritis.
    Hebert LA; Birmingham DJ; Shen XP; Cosio FG; Fryczkowski A
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S70-5. PubMed ID: 7533010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.